Literature DB >> 3888563

Severe hypoglycemia in diabetic patients: frequency, causes, prevention.

A F Casparie, L D Elving.   

Abstract

Over a 12-mo period, the frequency of severe hypoglycemic episodes was measured in a population of approximately 400 (50% type I) diabetic patients treated with insulin. There were 32 severe insulin reactions in 26 patients, a patient-yr incidence of 8%. The major precipitating causes were patients' errors (nine), and too much insulin or a wrong combination (six). In seven cases no cause could be found. For the group as a whole there was clear evidence of overtreatment as measured by insulin doses (0.89 +/- 0.43 U/kg/day versus 0.65 +/- 0.34 U/kg/day in a convenience group of 100 patients from the same diabetic population [P less than 0.05] ). Furthermore, 6-12 mo after the event the mean insulin dose had decreased from 0.82 +/- 0.25 to 0.69 +/- 0.27 U/kg/day in the subgroup of 20 hypoglycemic patients that could be followed (P less than 0.001). The mean HbAlc levels of the hypoglycemic group and the control group differed significantly (8.1 +/- 1.3% versus 8.7 +/- 1.7%, P less than 0.05). Six to 12 mo after the reaction, the mean HbAlc level in the follow-up subgroup rose from 8.1 +/- 1.3% to 9.1 +/- 1.1% (P less than 0.05). Patients' errors as a cause of the insulin reaction were not only the result of the patients' deficient knowledge but more often of lack of alertness and carelessness. We conclude that it is not possible to prevent all the severe hypoglycemic reactions in diabetic patients. However, besides avoiding overtreatment by the physician, teaching patients to respond more adequately to changing circumstances in daily life or to warning signs could also reduce the incidence of hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888563     DOI: 10.2337/diacare.8.2.141

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  The effect of genetically engineered glucagon on glucose recovery after hypoglycaemia in man.

Authors:  A Hvidberg; S Jørgensen; J Hilsted
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  Hypoglycemia--a major risk of insulin therapy.

Authors:  K R Feingold
Journal:  West J Med       Date:  1991-04

3.  Comparison of intramuscular glucagon and intravenous dextrose in the treatment of hypoglycaemic coma in an accident and emergency department.

Authors:  A W Patrick; A Collier; D A Hepburn; D J Steedman; B F Clarke; C Robertson
Journal:  Arch Emerg Med       Date:  1990-06

Review 4.  Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls.

Authors:  Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

Review 5.  Does fall in tissue glucose precede fall in blood glucose?

Authors:  F Sternberg; C Meyerhoff; F J Mennel; H Mayer; F Bischof; E F Pfeiffer
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

6.  Awareness and use of glucagon in diabetics treated with insulin.

Authors:  D M Matthews; A W Patrick; D A Collier; H A Kellett; J M Steel; B F Clarke; C C MacIntyre
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

Review 7.  Management of antidiabetic medications in overdose.

Authors:  H A Spiller
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 8.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

9.  Risk of severe hypoglycaemia in insulin treated diabetic patients transferred to human insulin: a case control study.

Authors:  M Egger; G D Smith; H Imhoof; A Teuscher
Journal:  BMJ       Date:  1991-09-14

10.  Global regulations on diabetic treated with insulin and their operation of commercial motor vehicles. DiaMond Project Group on Social Issues.

Authors: 
Journal:  BMJ       Date:  1993-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.